Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-754807 plus Cetuximab in Advanced Solid Tumors
NCT00908024Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of BMS-754807 in colorectal cancer (CRC), head and neck cancer (HNC), solid tumor, sponsored by Bristol Myers Squibb. Started Oct 2009; status: terminated.
02
Drugs
BMS-754807
03
Conditions
colorectal cancer (CRC)head and neck cancer (HNC)solid tumor
Beyond the preview
Go deeper on NCT00908024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908024.